Diana Alieksieieva

Ms. Diana Alieksieieva

Enamine (Ukraine), Kyiv, Kyyiv, Misto, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
AGAnastasiia Gryniukova
Anastasiia Gryniukova
PBPetro Borysko
Petro Borysko
IMIryna Myziuk
Iryna Myziuk
DADiana Alieksieieva
Diana Alieksieieva
DHDiana Hodyna
Diana Hodyna
STSergey Tcherniuk
Sergey Tcherniuk

24 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ARAlexey V. Rayevsky
Alexey V. Rayevsky
APAndrii Sergiyovych Poturai
Andrii Sergiyovych Poturai
KIKravets Iryna
Kravets Iryna
APAlexander E. Pashenko
Alexander E. Pashenko
TBTatiana A. Borisova
Tatiana A. Borisova
Alexandre VarnekAlexandre Varnek
Alexandre Varnek
New models for ACE2 receptor binding, based on QSAR and docking algorithms were developed, using XRD structural data and ChEMBL 26 database hits as training sets. The selectivity of the potential ACE2-binding ligands towards Neprilysin (NEP) and ACE was evaluated. The Enamine screening collection (3.2 million compounds) was virtually screened according to the above models, in order to find possible ACE2-chemical probes, useful for the study of SARS-CoV2-induced neurological disorders. An enzymology inhibition assay for ACE2 was optimized, and the combined diversified set of predicted selective ACE2-binding molecules from QSAR modeling, docking, and ultrafast docking was screened in vitro. The in vitro hits included two novel chemotypes suitable for further optimization.

7 May 2026 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
OSOleh Shyshlyk
Oleh Shyshlyk
VSVladyslav Stadnichenko
Vladyslav Stadnichenko
ODOleksandr Diachenko
Oleksandr Diachenko
ICIryna Chernysh
Iryna Chernysh
ABAnna Beshtynarska
Anna Beshtynarska
OGOleksandr Grygorenko
Oleksandr Grygorenko
Comprehensive SAR studies in a series of phenyl dihydrouracil (PDHU)-derived PROTACs led to the discovery of novel nanomolar BRD4 degraders.